You are here

  • Home
  • Archive
  • Volume 14, Issue 11
  • Cost-effectiveness analysis of trifluridine/tipiracil in the treatment of heavily pretreated metastatic gastric cancer from the perspective of Chinese healthcare system

Article info

Article menu

Download PDFPDF

Health economics
Original research
Cost-effectiveness analysis of trifluridine/tipiracil in the treatment of heavily pretreated metastatic gastric cancer from the perspective of Chinese healthcare system

Authors

  • Ting Ying School of Pharmacy, Anhui Medical University, Hefei, Anhui, China Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, Anhui, China PubMed articlesGoogle scholar articles
  • Runan Xia School of Pharmacy, Anhui Medical University, Hefei, Anhui, China Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, Anhui, China PubMed articlesGoogle scholar articles
  • Yuanyuan Zhang Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, Anhui, China Anhui Provincial Drug Regulatory Scientific Research Center, Anhui Medical University, Hefei, Anhui, China PubMed articlesGoogle scholar articles
  • Jiahui Dai School of Pharmacy, Anhui Medical University, Hefei, Anhui, China Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, Anhui, China PubMed articlesGoogle scholar articles
  • Yadong Wang School of Pharmacy, Anhui Medical University, Hefei, Anhui, China Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, Anhui, China PubMed articlesGoogle scholar articles
  • Xuefeng Xie Anhui Provincial Drug Regulatory Scientific Research Center, Anhui Medical University, Hefei, Anhui, China Key Laboratory of Public Health Social Governance, Philosophy and Social Sciences of Anhui Province, Anhui Medical University, Hefei, Anhui, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Xuefeng Xie; xiexuefengahmu{at}126.com
View Full Text

Citation

Ying T, Xia R, Zhang Y, et al
Cost-effectiveness analysis of trifluridine/tipiracil in the treatment of heavily pretreated metastatic gastric cancer from the perspective of Chinese healthcare system
BMJ Open 2024;14:e080846. doi: 10.1136/bmjopen-2023-080846

Publication history

  • Received October 16, 2023
  • Accepted October 11, 2024
  • First published November 7, 2024.
Online issue publication 
November 07, 2024
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.